Pharmaceutical News

RSS
ALL initiative three-year clinical observational study results published

ALL initiative three-year clinical observational study results published

New study underscores lack of appropriate government action to ensure safety of vaccines

New study underscores lack of appropriate government action to ensure safety of vaccines

Array BioPharma to present poster on ARRY-403 glucokinase activator

Array BioPharma to present poster on ARRY-403 glucokinase activator

Molecular mechanisms of BN108 and timosaponin AIII described in a journal

Molecular mechanisms of BN108 and timosaponin AIII described in a journal

sNDA for Clonicel submitted to the FDA

sNDA for Clonicel submitted to the FDA

Clinical study results demonstrate the efficacy of AFRESA inhalation powder

Clinical study results demonstrate the efficacy of AFRESA inhalation powder

Change in Heparin manufacturing - expected to decrease the potency

Change in Heparin manufacturing - expected to decrease the potency

Actavis' clients launch generic Atorvastatin in Spain

Actavis' clients launch generic Atorvastatin in Spain

Mayo study reveals infliximab reduces the need for colectomy

Mayo study reveals infliximab reduces the need for colectomy

HRA Pharma launches its new generation emergency contraceptive in Europe

HRA Pharma launches its new generation emergency contraceptive in Europe

GSK allowed access to DiscoveRx' PathHunter ß-Arrestin parental cell lines and reagents

GSK allowed access to DiscoveRx' PathHunter ß-Arrestin parental cell lines and reagents

Advaxis announces Phase I trial results of its ADXS11-001 therapeutic cancer vaccine

Advaxis announces Phase I trial results of its ADXS11-001 therapeutic cancer vaccine

First prescription foam formulation of benzoyl peroxide available

First prescription foam formulation of benzoyl peroxide available

Health Canada approves VIBATIV for treating complicated skin and skin structure infections

Health Canada approves VIBATIV for treating complicated skin and skin structure infections

Addrenex submits a sNDA to the FDA for Clonicel

Addrenex submits a sNDA to the FDA for Clonicel

Diamyd Medical signs agreement with Inclinix to conduct global Phase III program

Diamyd Medical signs agreement with Inclinix to conduct global Phase III program

Scientific Advisory Board to provide guidance to support the development of FST-100

Scientific Advisory Board to provide guidance to support the development of FST-100

CVS Caremark to offer vouchers worth $3 million for free seasonal flu shots

CVS Caremark to offer vouchers worth $3 million for free seasonal flu shots

FDA releases first draft guidance on Risk Evaluation and Mitigation Strategies for select drugs

FDA releases first draft guidance on Risk Evaluation and Mitigation Strategies for select drugs

Study aims to discover effective antibiotics to fight against hard-to-treat microbes

Study aims to discover effective antibiotics to fight against hard-to-treat microbes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.